BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33472196
Number of visits today
7412
Number of downloads
16655900
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Nigro E, Daniele A, Salzillo A, Ragone A, Naviglio S, Sapio L. AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments. Int J Mol Sci 2021;22:5569. [PMID: 34070338 DOI: 10.3390/ijms22115569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Yan W, Gao S, Zhang Q, Qi J, Liu G, Teng Y, Wang J, Yan S, Ji B. AdipoRon Inhibits Neuroinflammation Induced by Deep Hypothermic Circulatory Arrest Involving the AMPK/NF-κB Pathway in Rats. Pharmaceutics 2022;14. [PMID: 36432657 DOI: 10.3390/pharmaceutics14112467] [Reference Citation Analysis]
2 Ragone A, Salzillo A, Spina A, Naviglio S, Sapio L. Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines. Front Pharmacol 2022;13:837503. [PMID: 35273510 DOI: 10.3389/fphar.2022.837503] [Reference Citation Analysis]
3 Kelder J, Pang Y, Dong J, Schaftenaar G, Thomas P. Molecular Modeling, Mutational Analysis and Steroid Specificity of the Ligand Binding Pocket of mPRα ( PAQR7): Shared Ligand Binding With AdipoR1 and its Structural Basis. J Steroid Biochem Mol Biol 2022;:106082. [PMID: 35189329 DOI: 10.1016/j.jsbmb.2022.106082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sharma A, Mah M, Ritchie RH, De Blasio MJ. The adiponectin signalling pathway - A therapeutic target for the cardiac complications of type 2 diabetes? Pharmacol Ther 2021;:108008. [PMID: 34610378 DOI: 10.1016/j.pharmthera.2021.108008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345